Hexavalent combination vaccine: programme guidance
Guidance for healthcare professionals on the hexavalent vaccine programme for babies born after 1 August 2017.
Applies to England
Documents
Details
All babies born on or after 1 August 2017 are eligible for the hexavalent vaccine, which includes hepatitis B (HepB), for their primary immunisations.
In 2022, the UK Health Security Agency (UKHSA) will supply Vaxelis® in addition to Infanrix hexa® for use in the primary immunisation schedule.
This document provides information about the 2 hexavalent vaccines for healthcare practitioners who are involved in delivering or advising on the infant primary vaccination programme. Although originally published as 2 separate documents in 2017 (routine programme guidance and selective programme guidance) this updated version combines these 2 documents.
Last updated 13 May 2024 + show all updates
-
Added updated guidance and training slide set.
-
Updated information on incomplete or uncertain vaccination histories and stability of Vaxelis.
-
Added updated information for healthcare practitioners and link to updated training slide set.
-
Updated with revised infant PCV schedule and removed Hepatitis B pre-school booster recommendation.
-
Routine programme guidance has been updated to include additional information about action to take when hexavalent vaccine is given when pentavalent should have been given.
-
The routine and selective guidance documents have been revised to comply with accessibility guidelines.
-
First published.